<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92-vaccines-08-00531">
 <label>92.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Argilaguet</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Pérez-Martin</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Gallardo</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Salguero</surname>
    <given-names>F.J.</given-names>
   </name>
   <name>
    <surname>Borrego</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Lacasta</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Accensi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Díaz</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Nofrarias</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Pujols</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells</article-title>
  <source>Vaccine</source>
  <year>2011</year>
  <volume>29</volume>
  <fpage>5379</fpage>
  <lpage>5385</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2011.05.084</pub-id>
  <pub-id pub-id-type="pmid">21679736</pub-id>
 </element-citation>
</ref>
